Can a Sweat Assay’s Lower Number Prove Greater Amphetamine Sensitivity Than a Blood Assay?

Written by

in

A quantification limit of 2 ng per sweat patch cannot be ranked against 50 ng per milliliter of blood simply by comparing the numbers two and 50. The denominators describe different quantities. Gomes and colleagues’ 2024 analytical study provides a useful example of why cross-matrix sensitivity claims need more than a table of reporting limits.

A method for a defined collection system

The investigators developed disposable-pipette extraction with strong cation-exchange tips followed by gas chromatography–mass spectrometry. They validated target measurements using fortified sweat preparations and applied the method to 30 samples from adult volunteers attending a treatment service in Ribeirão Preto, Brazil.

Laboratory-made patches were placed on the back after skin cleaning with isopropanol, worn for 24 hours and stored at −20°C after removal. These details define the specimen. They do not describe a momentary forehead wipe, a measured volume of freshly secreted sweat or a blood draw at a known time after dosing.

Keep the analyte and analytical limit together

Table 1 lists amphetamine’s detection limit as 1 ng/patch and lower quantification limit as 2 ng/patch. Methamphetamine’s corresponding limits were 2 and 3 ng/patch. A detection limit and a quantification limit serve different purposes: recognizing a signal does not guarantee that an exact amount meets quantitative performance criteria.

The paper compared its results with earlier studies using blood and oral fluid, including a blood method reporting a 50 ng/mL lower quantification limit for amphetamine and methamphetamine. The cited blood study was not independently reproduced in this experiment. More fundamentally, a mass per patch and a mass per fluid volume cannot establish a simple sensitivity ranking.

What information would make the comparison meaningful?

One would need to define the clinical or forensic question, the collection procedure, the amount of specimen represented, the extraction and analytical criteria, and the relationship between exposure and the measured compartment. Even knowing the extraction-liquid volume would not reveal how much sweat the patch originally collected.

A 24-hour patch accumulates material during a collection interval. A blood measurement represents a different biological compartment at a particular sampling event. Neither the smaller reported number nor a longer collection interval proves that a method better identifies recent impairment or detects every relevant exposure.

Validation success is not an authentic methamphetamine finding

The application study did not detect amphetamine, methamphetamine or MDEA in the 30 collected samples. The authors identified absence of exposure or amounts below the detection limits as possible explanations. It would be incorrect to describe this as 30 confirmed amphetamine-positive specimens or as proof that all volunteers had never used those drugs.

MDMA and MDA were detected in one volunteer’s sample; these are separate analytes. Additional full-scan examination reported ethylamphetamine, which also must not be relabeled amphetamine or methamphetamine. The method’s calibration and validation for named targets do not automatically create quantitative validation for every additional full-scan identification.

Quality controls still require careful reading

The validation assessed precision, accuracy, extraction recovery, matrix effects, carryover, selectivity and stability. Stability experiments covered approximately 12 hours at room temperature and two freeze–thaw cycles under the specified protocol, rather than all possible long-term storage conditions.

The paper’s title refers to fourteen substances, while its target table lists 16. That internal count difference should not be resolved by silently deleting analytes. For an actual laboratory application, the specified analyte’s validation record is more informative than a headline panel count.

What the study can support

It supports the reported analytical capability in a defined sweat-patch procedure and demonstrates application to authentic samples. It does not establish blood-equivalent amphetamine amounts, dose reconstruction, exact time of use or an impairment threshold. When a scientific comparison uses unlike units, the correct response is to preserve the measurement distinction rather than manufacture a conversion.

Source

Gomes NC, Cabrices OG, De Martinis BS. Innovative disposable pipette extraction for concurrent analysis of fourteen psychoactive substances in drug users’ sweat. Journal of Chromatography A. 2024;1730:465136. doi:10.1016/j.chroma.2024.465136. Analytical validation and observational specimen application; earlier method values are discussed through this supplied source.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *